Syphilis Testing Algorithm
For syphilis screening, use either the traditional algorithm (nontreponemal test first, followed by treponemal confirmation) or the reverse algorithm (treponemal test first, followed by nontreponemal confirmation), as both demonstrate comparable diagnostic performance, though the reverse algorithm offers automation advantages in high-volume settings. 1, 2
Traditional Algorithm (Nontreponemal First)
This approach begins with:
- Initial screening: RPR (Rapid Plasma Reagin) or VDRL (Venereal Disease Research Laboratory) test
- Confirmation of reactive results: Treponemal test such as FTA-ABS (Fluorescent Treponemal Antibody Absorbed), TPPA (Treponema pallidum Particle Agglutination), or enzyme immunoassay 3, 4
Key advantages: Lower false-positive rate in low-prevalence populations; nontreponemal titers directly indicate disease activity 5, 6
Critical requirement: Always report complete endpoint titers (not just ">1:32") to enable proper treatment monitoring 7
Reverse Algorithm (Treponemal First)
This approach begins with:
- Initial screening: Automated treponemal test (chemiluminescence immunoassay or enzyme immunoassay)
- Confirmation of reactive results: Quantitative nontreponemal test (RPR or VDRL)
- If nontreponemal is negative: Perform second treponemal test (TPPA or different methodology) to distinguish true positives from false positives 4, 8, 1
Key advantages: Allows laboratory automation, higher sensitivity for detecting latent syphilis and previously treated cases 9, 10, 2
Important caveat: Will identify patients with past treated infections (who remain treponemal-positive for life), requiring additional testing to determine if infection is active 8, 11
Performance Comparison
Recent large-scale data demonstrates:
- Agreement between algorithms: 99.996% concordance with kappa value of 0.999 in populations of ~120,000 subjects 2
- Sensitivity for active infection: Both algorithms approach 100% when properly implemented 9
- Sequential automated immunoassays: Using two different treponemal tests sequentially shows promise, with false-positive rates as low as 0.08% 10
Population-Specific Recommendations
Pregnant Women
- Screen at first prenatal visit with either algorithm 3
- High-risk patients: Repeat testing in third trimester and at delivery 3
- Risk factors include: poverty, sex work, illicit drug use, communities with high syphilis prevalence, southern US residence 3
Men Who Have Sex With Men (MSM)
- Screen at least annually, every 3-6 months if high-risk (multiple/anonymous partners, methamphetamine use) 4
General Population
- Screen individuals in correctional facilities, commercial sex workers, those exchanging sex for drugs, and contacts of infectious syphilis cases 4
Critical Testing Principles
Both treponemal AND nontreponemal tests are required for diagnosis - a single positive test is insufficient 4, 8
For treatment monitoring: Use the same nontreponemal test (VDRL or RPR) from the same laboratory when possible, as results are not directly comparable between methods 5, 6
Fourfold titer change (two dilutions, e.g., 1:16 to 1:4) indicates clinically significant difference in disease activity 5, 6
Common Pitfalls
- False positives: Nontreponemal tests can be reactive in pregnancy, autoimmune diseases, HIV, hepatitis C, malaria, and other conditions - always confirm with treponemal testing 5, 6, 12
- Prozone phenomenon: Very high antibody titers can cause false-negative nontreponemal results; dilute samples if clinical suspicion is high despite negative screening 12
- Serofast state: Some patients maintain low nontreponemal titers indefinitely after successful treatment 5, 6
- Treponemal tests remain positive for life in most patients, making them unsuitable for assessing treatment response 5, 6
Current Practice Patterns
As of 2015, approximately 63% of US laboratories use the traditional algorithm, 16% use the reverse algorithm, and this is shifting toward increased automation 11. The CDC 2024 laboratory recommendations recognize both approaches as valid 1.